PharmaEssentia Corporation Stock Price

TWSE:6446 Community·NT$240.1b Market Cap

0 Narratives written by author
0 Comments on narratives written by author
8 Fair Values set on narratives written by author

Create a narrative

6446 Share Price Performance

NT$0

-435.24 (-100.00%)

NT$0

-435.24 (-100.00%)

NT$0

Wed, 22 Apr 26

Share Pricen/a

6446 Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Exceptional growth potential with flawless balance sheet.

1 Risk

2 Rewards

View Full Analysis

PharmaEssentia Corporation Key Details

Last Reported Earnings

Dec 31, 2025

Next Reporting Earnings

n/a

: 13.59
: 89.23%
: 32.27%
: 0.2%

View Full Analysis

About 6446

Founded: 1990
Employees: n/a
CEO: Ko-Chung Lin
WebsiteView website: www.pharmaessentia.com

PharmaEssentia Corporation, a biopharmaceutical company engages in medicine discovery, supplements in developing specialty pharmaceutical reagents, API, and new drug patterns developments in the Americas, Europe, Asia, and Taiwan. Its products include BESREMi, an interferon therapy indicated for polycythemia vera, essential thrombocythemia, PMF, and adult T-cell leukemias. The company also develops Ropeg + anti PD-1; PEG-IL-2 (P11838); PEG-Cytokines; PD-1-IL-2v; ADC; ADCS; NY-ESO-1 TCR-T; and Novel TCR-T for the treatment of solid tumor and immunology. PharmaEssentia Corporation was founded in 1990 and is headquartered in Taipei, Taiwan.